Black Diamond Therapeutics (BDTX) Peer Comparison

$2.13

$0.03 (1.19%)

As on 04-Sep-2026 13:34EDT

Market cap

$128 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	128	16,765	16,261	13,492	12,332
Revenue ($ Mln)	--	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-42.56	491.50	755.85	860.62	-325.10
Net Margin (%)	--	17.67	71.69	35.33	-25.32
RoE (%)	-40.86	110.09	--	42.98	-57.72
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	1.36	39.29	9.76	7.42	23.98

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	0.00	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	0.09	1,982.07	103.47	85.67	109.42
Gross Profit	69.68	760.62	588.53	2,236.43	902.26
Operating Expenses	51.90	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-51.90	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-42.56	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.00	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-42.56	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	96.09	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	13.10	187.89	384.48	288.55	346.72
Current Liabilities	15.84	1,435.43	464.70	361.93	374.20
Total Liabilities	143.01	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	9.64	1,006.90	895.24	1,243.41	45.47
Current Assets	115.39	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	143.01	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	16.97	120.10	449.89	165.93	347.75
Net Current Assets	99.55	-385.14	0.00	888.90	824.98

Cashflow ($ Mln)

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	29.61	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	-44.91	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	-0.15	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	18.92	53.56	-30.01	32.82	-31.49
ROE (%)	-40.86	110.09	163.18	42.98	-57.72
ROA (%)	-26.26	15.64	26.53	29.32	-22.97
EBIT Margin (%)	--	21.13	5.73	31.04	-18.97
Net Margin (%)	31.95	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	--	24.67	114.85	9.23	149.04
EBIT Growth (%)	-384.53	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	-394.72	17.50	378.76	42.89	-15.32
EPS Growth (%)	-414.46	26.84	353.27	50.42	-0.64
Book Value Growth (%)	-28.25	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	6.20	36.06	-59.76	15.79	-45.32
Price / Book Value	1.24	35.44	-80.42	5.72	21.68
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	1.27	28.08	-121.54	12.44	-47.02
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.00	0.00	0.65
Short term debt to equity ratio	0.04	0.00	0.05	0.00	0.00
Current Ratio	7.28	0.73	2.99	3.46	3.20
Quick Ratio	7.28	0.73	2.32	3.38	2.94
Interest Coverage	--	--	1.62	--	-19.80

Operating Efficiency Ratios

	Black Diamond Therapeutics (BDTX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	--	15.88	21.25	13.74	14.98
Asset Turnover	0.00	0.89	0.37	0.83	0.91
Receivable days	--	50.42	85.52	43.48	35.88
Inventory Days	--	--	1,056.70	96.17	354.23
Payable days	2,576.98	6.26	331.01	147.97	300.79
Cash Conversion Cycle	--	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly